Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000542
Filing Date
2024-12-17
Accepted
2024-12-17 16:44:12
Documents
1
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3462
  Complete submission text file 0001610717-24-000542.txt   5089
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Issuer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065
Business Address
Reider Paul (Reporting) CIK: 0001970033 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36721 | Film No.: 241556323